
Compass Pathways plc (Nasdaq: CMPS) is a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care.
The Company is headquartered in London, UK, with a U.S. office in New Jersey. We believe mental health patients deserve the possibility of a better future. Our initial focus is developing COMP360 psilocybin, a proprietary, investigational, synthetic psilocybin treatment under evaluation for treatment-resistant depression (TRD) and post-traumatic stress disorder (PTSD). COMP360 is a potentially first-in-class treatment and has Breakthrough Therapy designation from the U.S. Food and Drug Administration (FDA), as well as Innovative Licensing and Access Pathway (ILAP) designation in the UK for TRD.
We are leading the world’s largest classic psychedelic clinical program in TRD, and building upon that robust foundation, we are executing a late-stage trial evaluating COMP360 for PTSD, another condition with high unmet need. Our goal is to advance treatments that move the field of psychiatry towards treatment options that offer rapid onset and sustained durability with infrequent dosing. - Compass Pathways
The Thought Leader Liaison (TLL) is a field-based commercial role responsible for developing and executing regional engagement strategies with key opinion leaders (KOLs), emerging thought leaders, and professional societies to support the future commercialization of COMP360.
As an extension of the Compass Marketing team, the TLL gathers actionable marketplace insights, serves as a critical link between regional stakeholders and headquarters, and helps inform brand strategy and launch readiness. Through compliant, customer-centric engagement and cross-functional collaboration, the TLL supports strategic decision-making, identifies partnership opportunities, and delivers a cohesive stakeholder experience that advances organizational goals and improves patient outcomes.
This role involves significant travel to national and regional medical congresses, professional society meetings, advisory boards, field engagements, and cross-functional business meetings.
Location: Field based on the East Coast, United States.
Reports to: Director, Promotional Medical Education.
(include but not limited to):
Our compensation package for permanent hires includes base salary, discretionary bonus, and equity, alongside our comprehensive benefits offering.
Please note that the base salary range is a guideline, and individual total compensation will vary based on factors such as qualifications, skill level, competencies, and work location.
【Base salary per annum】:
$170,000—$230,000 USD
For an overview of our benefits package and compensation information, please visit "Joins us - Our Benefits".
These include flexibility & generous time off, parental & reproductive support, health & medical, mental health & wellbeing and Financial health.
We are committed to building a workplace where everyone’s wellbeing matters. If you need reasonable accommodation during the interview process to be at your best, please let our recruiting team know.
We are proud of our commitment to diversity and equality (pursuant to the Equality Act 2010). We do not discriminate based upon race, religion or belief, colour, nationality, ethnic or national origin, gender, pregnancy or maternity, marital or civil partner status, sexual orientation, gender reassignment, age or disability.
Compass Pathways is proud to be an equal opportunity employer. All employment decisions are based on business needs, job requirements, and individual qualifications, without regard to race, religion, color, national origin, sex (including pregnancy, childbirth, and related medical conditions), ethnicity, age, disability, sexual orientation, gender identity, gender expression, military service, genetic information, familial or marital status, or any other status, category, or characteristic protected by applicable law.
Unfortunately, we cannot sponsor employment visas and can only accept applications if you have employment rights in the country to which you are applying.
All data is confidential and protected by all legal and data privacy requirements, please see our recruitment Privacy Notice to learn more about how we process personal data.

We are Compass, a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care.
We believe people living with mental health conditions deserve the possibility of a better future. Our initial focus is advancing COMP360, a proprietary, investigational synthetic psilocybin treatment being evaluated for treatment-resistant depression (TRD) and post-traumatic stress disorder (PTSD). Our goal is to advance treatments that move the field of psychiatry towards treatment options that offer rapid onset and sustained durability, with infrequent dosing.
We’re driven by our purpose of unlocking pathways to be—opening futures filled with possibility. Together, we’re on an ambitious journey toward enabling people living with mental health conditions to find clarity through self-discovery.
Every journey needs a Compass.